Evaluation and Modeling with the Therapeutic Effects Group
Members
Stagiaire
UCBL

Maîtresse de conférences - praticienne hospitalière
UCBL
Tel: 04 72 11 94 07
Stagiaire
UCBL
Maître de conférences - praticien hospitalier
UCBL
Tel: 33 04 72 32 34 87

Professeur des universités - médecin généraliste
UCBL
Tel: 04 78 74 18 18

Maîtresse de conférences
UCBL
Tel: 33 04 78 78 57 83

Professeure des universités - médecin généraliste
UCBL
Tel: 04 78 77 72 86

Professeur d'université - praticien hospitalier
UCBL
Tel: 04 72 44 81 42
Doctorante
HCL
Assistant hospitalier universitaire
UCBL
Doctorant
UCBL
Tel: 04 72 44 81 42

Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 16 80 99

Doctorante
autre
Tel: 04 72 44 81 42

Praticien hospitalier
HCL
Tel: 04 72 44 81 42

Professeur d'université - praticien hospitalier émérite
UCBL

Professeur d'université - praticien hospitalier
UCBL
Tel: 04 27 85 77 32

Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 78 86 33 01

Post-doc
UCBL

Maîtresse de conférences - praticienne hospitalière
UCBL
Maître de conférences - praticien hospitalier
UCBL
Tel: 04 72 11 94 20

Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 12 94 37
Doctorante
UCBL
Tel: 04 72 44 81 42
Doctorante
HCL
EMET presentation
The EMET team brings together doctors, pharmacists and research professors specializing in the evaluation and use of drug and non-drug therapies, around a single project built on two axes:
- the evaluation of therapies in clinical trials or observational studies;
- the construction of explanatory and predictive models, to better understand and therefore predict the effect of therapies, simulate their impacts at the individual and population level, and improve the innovation paradigm.
The EMET team is therefore part of two major dynamics in therapy: analysis of the level of evidence and precision medicine.
The fields of application are cardiovascular and metabolic diseases, primary care medicine, rare pediatric diseases (including genetic and autoimmune diseases), oncology and infectious diseases.
EMET members implement approaches using different mathematical models: direct comparison and network meta-analysis, pharmacokinetic/pharmacodynamic analysis, Bayesian networks and machine learning.
Education
The EMET team is specially involved in the teaching of pharmacology and therapeutics and the modeling of the treatment effect through the coordination of the Masters 2 Clinical Evaluation (EC) and Pharmacology modeling and clinical trials (PHAME), Interpretation of Therapeutic Trials (IET), Training of investigators in clinical drug trials (FIEC) and Training of clinical research assistants and clinical study technicians (FARCTEC). Teacher-researchers are also involved in the first (pharmacology), second (pharmacology / therapeutics, pharmacy) and third cycles (general medicine, pediatrics, internal medicine) in health training courses.
Society involvement
The members of the EMET team through their work and their interactions with the other components of the LBBE, National societies, governmental (HAS) or international (EMA) agencies, and the Hospices Civils de Lyon, are invested in current societal issues: rationalization of the use of health product resources, research ethics, gender equality, rationality of approaches in analyzing the diversity of human populations.
Publications
Display of 151 to 180 publications on 628 in total
Meta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortality
Scientific Reports . 11 ( 1 ) : 14728
Journal article
see the publicationSignificant Major Bleeding in Hospitalized Patients with COVID-19 Receiving Thromboprophylaxis
Thrombosis and Haemostasis . 121 ( 12 ) : 1670-1673
DOI: 10.1055/a-1477-4027
Journal article
see the publicationCharacteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tract
Seminars in Arthritis and Rheumatism . 51 ( 2 ) : 436-441
Journal article
see the publicationCharacteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tract
Seminars in Arthritis and Rheumatism . 51 ( 2 ) : 436-441
Journal article
see the publicationParaneoplastic polyarteritis nodosa in a patient with cutaneous T-cell lymphoma
The Lancet Haematology . 8 ( 3 ) : e240
Journal article
see the publicationDirect oral anticoagulants in the treatment of acute venous thromboembolism in patients with obesity: A systematic review with meta-analysis
Pharmacological Research . 163 : 105317
Journal article
see the publicationDPP-4 Inhibitors and Respiratory Infection: A Systematic Review and Meta-analysis of the Cardiovascular Outcomes Trials
Diabetes Care . 44 ( 3 ) : e36-e37
DOI: 10.2337/dc20-2018
Journal article
see the publicationPrevention of venous thromboembolism in nephrotic syndrome: the quest towards precision medicine
Nephrology Dialysis Transplantation . 36 ( 7 ) : 1151-1154
DOI: 10.1093/ndt/gfaa337
Journal article
see the publicationBladder endometriosis: Preoperative MRI analysis with assessment of extension to ureteral orifices
Diagnostic and Interventional Imaging . 102 ( 4 ) : 255-263
Journal article
see the publicationSplenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment
American Journal of Hematology . 97 ( 1 ) : 10-17
DOI: 10.1002/ajh.26378
Journal article
see the publicationArterial and venous thromboembolism in COVID-19: a study-level meta-analysis
Thorax . 76 ( 10 ) : 970-979
Journal article
see the publicationPopulation Pharmacokinetic Modeling and Dosing Simulations of Tobramycin in Pediatric Patients with Cystic Fibrosis
Antimicrobial Agents and Chemotherapy . 65 ( 10 ) : e0073721
DOI: 10.1128/AAC.00737-21
Journal article
see the publicationParametric and Nonparametric Methods in Population Pharmacokinetics: Experts’ Discussion on Use, Strengths, and Limitations
Journal of Clinical Pharmacology . 62 ( 2 ) : 158-170
DOI: 10.1002/jcph.1993
Journal article
see the publicationEstimating renal function when adjusting the dosage of antibiotics: Facts and fables
Infectious Diseases Now . 51 ( 7 ) : 635-637
Journal article
see the publicationDrug-related problems among older patients: Analysis of 8 years of pharmacist's interventions
Annales Pharmaceutiques Françaises . 79 ( 5 ) : 511-521
Journal article
see the publicationPharmacokinetic/Pharmacodynamic Dosage Individualization of Cefepime in Critically Ill Patients: A Case Study
Therapeutic Drug Monitoring . 43 ( 4 ) : 451-454
Journal article
see the publicationTo Estimate or to Forecast? Lessons From a Comparative Analysis of Four Bayesian Fitting Methods Based on Nonparametric Models
Therapeutic Drug Monitoring . 43 ( 4 ) : 461-471
Journal article
see the publicationAdherence to oral antibiotic therapy in patients with bone and joint infection: A pilot study
Infectious Diseases Now . 51 ( 4 ) : 334-339
Journal article
see the publicationPharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection
Frontiers in Medicine . 8 : 583086
Journal article
see the publicationPharmacogenetic-guided glimepiride therapy in type-2 diabetes mellitus: a cost-effectiveness study
Pharmacogenomics Journal . 21 ( 5 ) : 559-565
Journal article
see the publicationNeeds for re-intervention on restored teeth in adults: a practice-based study
Clinical Oral Investigations . 26 ( 1 ) : 789-801
Journal article
see the publicationOlaparib in recurrent IDH-mutant high-grade glioma (OLAGLI).
57th Annual Meeting of the American Society of Clinical Oncology (2021 ASCO Annual Meeting) . 39 ( 15_suppl ) : 2007-2007
Conference paper
see the publicationEffect of periodontal treatment on the glomerular filtration rate, reduction of inflammatory markers and mortality in patients with chronic kidney disease: A systematic review
PLoS ONE . 16 ( 1 ) : e0245619
Journal article
see the publicationEvaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test
Clinical Chemistry . 67 ( 5 ) : 742-752
Journal article
see the publicationClinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study
Scientific Reports . 11 ( 1 ) : 14977
Journal article
see the publicationEconomic impact of clinical pharmaceutical activities in hospital wards: A systematic review
Research in Social and Administrative Pharmacy . 17 ( 3 ) : 497-505
Journal article
see the publicationRelationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol
Therapies . 76 ( 6 ) : 675-685
Journal article
see the publicationReference values for the external genitalia of full-term and pre-term female neonates
Archives of disease in childhood. Fetal and neonatal edition . 106 ( 1 ) : 39-44
Journal article
see the publicationReappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials
Thérapie .
Journal article
see the publicationRelationship Between Scorpion Stings Events and Environmental Conditions in Mainland France
Journal of Medical Entomology . 58 ( 6 ) : 2146-2153
DOI: 10.1093/jme/tjab109
Journal article
see the publication
You also, comment on this article